Carpal tunnel release
ProcedureTransection of flexor retinaculum for patients who have carpal tunnel syndrome
NCT Number: NCT05431101
Carpal Tunnel Syndrome is a prevalent condition, up to 9% in women and 0.6% in men. Surgical decompression in the most effective treatment. After surgery, approximately 1,8% of the patients develop a wound infection. Possibly, the type of sutures used can influence the prevalence of wound infection. In this RCT the incidence of infection is investigated between the use of absorbable versus non-absorbable sutures in carpal tunnel release.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Gelre Ziekenhuizen, Apeldoorn, Netherlands
Carpal Tunnel Syndrome is a prevalent condition; up to 9% in women and 0.6% in men. It causes complaints of paresthesia, pain, numbness and loss of strength. Surgical decompression is the most effective treatment. After surgery, approximately 1,8% of the patients develop a wound infection. Possibly, the type of suture material which is used can influence the prevalence of wound infection. In current clinical practice both absorbable and non absorbable sutures are used. In literature, various hypothesis are described: Absorbable sutures could give more reaction of macrophages and therefore a higher chance on infection. This would not be the case for non-absorbable sutures, since they will be removed. However, in literature, there is still not enough evidence for superiority of absorbable or non-absorbable suture. In this RCT the incidence of infection is investigated between the use of absorbable versus non-absorbable sutures in carpal tunnel release.
The primary outcome is the ASEPSIS wound score. This will be scored by independent investigators.
Use of antibiotics, handtherapy and extra outpatient visits will be recorded.
Patients are asked to register their NRS scores the first three weeks after surgery.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transection of flexor retinaculum for patients who have carpal tunnel syndrome
Time frame: 10 to 14 days post surgery
score based on a picture made of the wound 10-14 days post carpal tunnel release. Minimum score 0, maximum score 70, score above 40 is categorized as wound infection
Time frame: until three weeks post surgery
pain score, minimum score 0, maximum score 10. Unbearable pain is scored as 10, no pain is scored as 0.
Contact information is provided by the study sponsor or research team.
Gelre Hospitals
Other
Absorbable Versus Non-absorbable Sutures for Wound Closure in Carpal Tunnel Release: a Randomized Controlled Trial
Acronym: SENSE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07660913
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Izmir, Turkey (Türkiye)
View Trial DetailsNCT07614425
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Helsinki, Finland
View Trial DetailsNCT06239259
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Bangkok Noi, Bangkok, Thailand
View Trial DetailsNCT07324005
Carpal Tunnel Release, Carpal Tunnel Syndrome
Taipei, Taiwan
View Trial Details